Concepedia

Husain Attarwala

HA

12

Publications

1.4K

Citations

11

H-Index

2010

Active since

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Northeastern University

Moderna Therapeutics (United States)

Husain Attarwala is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

2010–2022

12

Publications

12

An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia

Alfica Sehgal, Scott Barros, Lacramioara Ivanciu et al. · Nature Medicine · 2015 · 290 citations

, , +9

Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates

Jayaprakash K. Nair, Husain Attarwala, Alfica Sehgal et al. · Nucleic Acids Research · 2017 · 258 citations · Full text

, , +16

TGN1412: From Discovery to Disaster

Husain Attarwala · Journal of Young Pharmacists · 2010 · 247 citations · Full text

, , +12

A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

Allison August, Husain Attarwala, Sunny Himansu et al. · Nature Medicine · 2021 · 165 citations · Full text

Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects

Bahru Habtemariam, Verena Karsten, Husain Attarwala et al. · Clinical Pharmacology & Therapeutics · 2020 · 159 citations

Rows per page

1–5 of 12